Serving as legal counsel to one of the nation’s leading providers of high-quality behavioral healthcare services in its proposed sale to a leading Tennessee-based healthcare provider. The transaction is expected to be completed in early 2023. See press release.
Represented strategic operator in structuring joint venture arrangement with large nonprofit health system involving acquisition of existing behavioral health hospital, transfer of existing inpatient psychiatric units of multiple acute care hospitals, and development of new 197-bed freestanding behavioral hospital.
Represented financial sponsor in acquisition of electronic medical records service provider for substance abuse facilities.
Represented national behavioral health provider in strategic acquisitions involving single facility and multi-facility targets.
Represented national operator in reorganization and development of management services organization.
Acted as lead regulatory counsel in multiple transactions involving the acquisition of substance use disorder clinics.
Represented national nonprofit health system in connection with the sale of inpatient and outpatient mental health and substance abuse facility.
Represented operator of behavioral health and addiction treatment centers in connection with debt refinancing.
Represented portfolio company of financial sponsor in connection with sale to strategic purchaser.
Represented management team of behavioral health company in connection with private equity recapitalization transaction.
Represented client on the divestiture of its portfolio of substance abuse and recovery facilities, and its facilities for individuals with intellectual and developmental disabilities.
Represented strategic operator of residential and outpatient mental health and substance abuse facilities in divestiture.
Advised national health system in regulatory considerations associated with expansion of psychiatric unit.
Advised national behavioral health provider in creation of telemedicine service line.
Advised addiction treatment systems and facilities on HIPAA and Part 2 compliance programs.
Advised national behavioral health provider in review and restructuring of compensation for the Eliminating Kickbacks in Recovery Act compliance.
Advised client in development of patient consent and authorization forms for acute care and substance abuse facilities.
Advised client on guidelines on employee reporting to the Department of Children’s Services and employee communications with the Department of Corrections.
Represented owner of behavioral health facilities in voluntary disclosure and DOJ/CMS settlement.
Represented a national operator of substance use disorder treatment facilities, on healthcare regulatory guidance, including federal fraud and abuse law compliance guidance, as well as privacy and security guidance on data sharing, breach reporting, vendor contracting and patient-facing consent and authorization issues under HIPAA and Part 2.
Represented addiction treatment company in its legal and regulatory risk assessment of its business as it entered a new phase of rapid growth in volume and geographic presence.
Advised client on DEA regulatory burdens on office-based use of opioid treatments, including the required inspections of treatment facilities.
Advised client on state board of medicine requirements for physicians engaged in office-based opioid treatments.
Advised client on federal and state guidelines regarding specimen collection in Suboxone clinics.
Advised client on federal and state requirements regarding the closure of facilities.
Advised opioid treatment facilities on state licensure requirements.
Represented owner of established methadone clinics before the legislative branches of state government.